Role of Imaging in the Evaluation of Patients at Risk for Sudden Cardiac Death
- 1 July 2015
- journal article
- review article
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 8 (7) , 828-845
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Incidence of sudden cardiac death in athletes: a state-of-the-art reviewBritish Journal of Sports Medicine, 2014
- β-Myosin Heavy Chain Variant Val606Met Causes Very Mild Hypertrophic Cardiomyopathy in Mice, but Exacerbates HCM Phenotypes in Mice Carrying Other HCM MutationsCirculation Research, 2014
- A systematic review and meta-analysis of genotype–phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutationsHeart, 2013
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic CardiomyopathyJACC, 2011
- Transmural Differences in Myocardial Contraction in Long-QT SyndromeCirculation, 2010
- Diagnostic, Prognostic, and Therapeutic Implications of Genetic Testing for Hypertrophic CardiomyopathyJACC, 2009
- Genetic Determinants of Sudden Cardiac DeathCirculation, 2008
- Myofilament Protein Gene Mutation Screening and Outcome of Patients With Hypertrophic CardiomyopathyMayo Clinic Proceedings, 2008
- Evolution of expression of cardiac phenotypes over a 4-year period in the $beta;-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathyJournal of Molecular and Cellular Cardiology, 2004
- Risk Stratification in the Long-QT SyndromeNew England Journal of Medicine, 2003